Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease (Q45417625)
Jump to navigation
Jump to search
scientific article published in November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease |
scientific article published in November 2010 |
Statements
1 reference
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease (English)
1 reference
Herbert Tilg
1 reference
Arthur Kaser
1 reference
1 November 2010
1 reference
1 reference